Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.8K
Cancer Therapies02:49

Cancer Therapies

7.9K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.9K
Tumor Immunotherapy01:27

Tumor Immunotherapy

611
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
611

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

High-fat diet and obesity each increase tumor cell proliferation and muscle wasting in experimental cancer cachexia.

American journal of physiology. Cell physiology·2026
Same author

Real-world comparison of mechanical thrombectomy vs. catheter-directed thrombolysis for the treatment of pulmonary embolism: a single-center retrospective study.

Frontiers in cardiovascular medicine·2026
Same author

ASO Visual Abstract: National Evaluation of the Management of Melanoma Patients with Multiple Positive Sentinel Lymph Nodes.

Annals of surgical oncology·2025
Same author

National Evaluation of the Management of Melanoma Patients with Multiple Positive Sentinel Lymph Nodes.

Annals of surgical oncology·2025
Same author

Impaired Fatty Liver Regeneration Post-major Resection: A Mitochondrial Problem.

Shock (Augusta, Ga.)·2025
Same author

Pancreatic Cancer Induces Population-Specific Switching of Myosin Isoforms and Discrete Activation of Cachexia Genes in Skeletal Muscle Myocytes.

bioRxiv : the preprint server for biology·2025

Related Experiment Video

Updated: Aug 9, 2025

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
06:38

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis

Published on: September 12, 2019

9.0K

Ablative Therapy in Non-HCC Liver Malignancy.

Tyler P Robinson1, Travis Pebror2, Matthew E Krosin2

  • 1Department of Surgery, Indiana University, Indianapolis, IN 46202, USA.

Cancers
|February 25, 2023
PubMed
Summary
This summary is machine-generated.

Ablative therapies offer a less invasive alternative to surgery for liver tumors, preserving more healthy liver tissue and improving patient outcomes. These methods are also suitable for managing recurrent liver tumors.

Keywords:
Irreversible Electroporationcryotherapyelectrochemotherapyhigh intensity focused ultrasoundlaser-induced thermotherapyliver malignancymicrowave ablationpercutaneous ethanol injectionphotodynamic therapyradiofrequency ablationstereotactic body radiotherapy

More Related Videos

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma
09:11

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma

Published on: May 24, 2024

532
Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy
08:54

Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy

Published on: May 8, 2018

14.3K

Related Experiment Videos

Last Updated: Aug 9, 2025

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
06:38

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis

Published on: September 12, 2019

9.0K
Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma
09:11

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma

Published on: May 24, 2024

532
Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy
08:54

Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy

Published on: May 8, 2018

14.3K

Area of Science:

  • Hepatobiliary Surgery
  • Interventional Radiology
  • Oncology

Background:

  • Surgical resection is a standard treatment for liver tumors, especially colorectal metastases.
  • Non-resective ablative therapies are gaining traction due to better tolerance and reduced complications.
  • These techniques preserve liver parenchyma, crucial for post-treatment function and managing recurrence.

Purpose of the Study:

  • To review the current landscape of ablative therapies for non-hepatocellular liver tumors.
  • To discuss various clinically available ablative approaches.

Main Methods:

  • Review of current literature and clinical practices.
  • Discussion of established and emerging ablative techniques.

Main Results:

  • Ablative therapies are increasingly favored for liver tumors.
  • These methods offer advantages in tolerability, morbidity, and mortality compared to surgery.
  • Preservation of liver parenchyma is a key benefit, aiding in managing recurrence.

Conclusions:

  • Ablative therapies represent a significant advancement in treating non-hepatocellular liver tumors.
  • They provide a valuable, less invasive option with improved functional outcomes.
  • The review highlights the clinical availability and application of these techniques.